Teva Pharmaceutical Industries Limited ( TEVA) - Key Metrics

TEVA Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $3.56 -$0.49 $0.35 $0.26
2026Q1 $3.44 $0.32 -$0.03 -$0.18
2025Q4 $4.10 $0.42 $1.01 $0.88
2025Q3 $3.91 $0.38 $0.32 $0.20
2025Q2 $3.64 $0.25 $0.20 $0.11

TEVA Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% -17.29
2026Q1 0% 23.53
2025Q4 0% 18.58
2025Q3 0% 13.29
2025Q2 0% 16.76

TEVA Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.78% 0%
2026Q1 -0.60% 0%
2025Q4 2.83% 0%
2025Q3 1.01% 0%
2025Q2 0.68% 0%

TEVA

Price: $41.10

52 week price:
18.83
41.10

Dividend Yield: 2.45%

Payout Ratio Range:
-300.00%
278.64%

Earnings Per Share: 0.60 USD

P/E Ratio: 57.43

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Israel

Volume: 6.4 million

Ebitda: -12.5 billion

Market Capitalization: 46.0 billion

Links: